Topical recombinant human acidic fibroblast growth factor: An effective therapeutic agent for facemask wearing-induced pressure sores
- 30 June 2020
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4), e13745
- https://doi.org/10.1111/dth.13745
Abstract
Protecting health care workers is crucial during coronavirus disease 2019 pandemic and facemask wearing is considered an effective measure to prevent severe acute respiratory syndrome coronavirus 2 infection. However, long-time use of a facemask can cause pressure sores on the ears and nose bridge and increase the risk of infection. The topical recombinant human acidic fibroblast growth factor (rh-aFGF) was used to cure pressure sores for health care workers at Zhongfaxincheng campus of Tongji Hospital. The results from a small sample size survey conducted in Zhongfaxincheng campuses of Tongji Hospital showed that treatment with topical rh-aFGF could significantly inhibit the progression of pressure sores and accelerate the wound healing with no apparent ill-effects. Therefore, we propose that topical rh-aFGF is an effective therapeutic agent for facemask wearing-induced pressure sores and worth of popularizing and applying.This publication has 9 references indexed in Scilit:
- Covid-19: countermeasure for N95 mask-induced pressure soreJournal of the European Academy of Dermatology and Venereology, 2020
- Wearing the N95 mask with a plastic handle reduces pressure injuryJournal of the American Academy of Dermatology, 2020
- Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19)International Journal of Nursing Studies, 2020
- Long-Term Toxicity Study of Topical Administration of a Highly-Stable rh-aFGF Carbomer 940 Hydrogel in a Rabbit Skin Wound ModelFrontiers in Pharmacology, 2020
- Proapoptotic effect of control‐released basic fibroblast growth factor on skin wound healing in a diabetic mouse modelWound Repair and Regeneration, 2015
- TAT-Mediated Acidic Fibroblast Growth Factor Delivery to the Dermis Improves Wound Healing of Deep Skin Tissue in RatPLOS ONE, 2015
- Acceleration of diabetic‐wound healing with PEGylated rhaFGF in healing‐impaired streptozocin diabetic ratsWound Repair and Regeneration, 2011
- Randomized, multicenter, double‐blind, and placebo‐controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial‐thickness burns and skin graft donor siteWound Repair and Regeneration, 2007
- Cellular and molecular basis of wound healing in diabetesJCI Insight, 2007